Article
Radio-sensitization of mutated KRAS G12C non-small cell lung cancer with KRAS G12C tyrosine kinase inhibitor and Carbon ions irradiation
2026-04-30
Abstract excerpt
<title>Abstract</title> <p> Non-small cell lung cancer (NSCLC) with <italic>KRAS</italic> <sup> <italic>G12C</italic> </sup> mutation is associated with poor prognosis and resistance to standard therapies. Sotorasib, a <italic>KRAS</italic> <sup>G12C</sup> tyrosine kinase inhibitor, has shown clinical efficacy, yet its interaction with different irradiation modalities remains unclear. This study aimed to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f636cb59-278f-586d-9d05-8210e41f4ad1
- DOI
- 10.21203/rs.3.rs-9469593/v1
